Hikma Pharmaceuticals USA Inc. v. Vanda Pharmaceuticals Inc.
Petition for certiorari denied on January 13, 2020
Issue: Whether patents that claim a method of medically treating a patient automatically satisfy Section 101 of the Patent Act, even if they apply a natural law using only routine and conventional steps. CVSG 12/6/2019.
| Date | Proceedings and Orders (key to color coding) |
|---|
| Oct 26 2018 | Application (18A461) to extend the time to file a petition for a writ of certiorari from November 12, 2018 to December 27, 2018, submitted to The Chief Justice. |
| Oct 31 2018 | Application (18A461) granted by The Chief Justice extending the time to file until December 27, 2018. |
| Dec 27 2018 | Petition for a writ of certiorari filed. (Response due January 28, 2019) |
| Jan 22 2019 | Motion to extend the time to file a response from January 28, 2019 to February 12, 2019, submitted to The Clerk. |
| Jan 23 2019 | Motion to extend the time to file a response is granted and the time is extended to and including February 12, 2019. |
| Jan 28 2019 | Brief amici curiae of Intellectual Property and Innovation Professors, Engine Advocacy, et al. filed. |
| Jan 28 2019 | Brief amici curiae of The Association for Accessible Medicines and Certain Individual Companies filed. |
| Feb 12 2019 | Brief of respondent Vanda Pharmaceuticals USA, Inc. in opposition filed. |
| Feb 26 2019 | Reply of petitioners Hikma Pharmaceuticals USA Inc., et al. filed. |
| Feb 27 2019 | DISTRIBUTED for Conference of 3/15/2019. |
| Mar 15 2019 | Letter of Hikma Pharmaceuticals USA Inc., et al. received. |
| Mar 18 2019 | The Solicitor General is invited to file a brief in this case expressing the views of the United States. |
| May 22 2019 | Amendment to Rule 29.6 Corporate Disclosure Statement filed with respect to brief in opposition of respondent Vanda Pharmaceuticals Inc. |
| Dec 06 2019 | Brief amicus curiae of United States filed. |
| Dec 20 2019 | Supplemental brief of petitioners Hikma Pharmaceuticals USA Inc., et al. filed. |
| Dec 23 2019 | DISTRIBUTED for Conference of 1/10/2020. |
| Dec 23 2019 | Supplemental brief of respondent Vanda Pharmaceuticals USA, Inc. filed. (Distributed) |
| Dec 26 2019 | Letter of December 26, 2019 from counsel for petitioner received. (Distributed) |
| Jan 13 2020 | Petition DENIED. |
